-
1Academic Journal
Συγγραφείς: M. I. Gonik, E. L. Bueverova, A. O. Bueverov, М. И. Гоник, Е. Л. Буеверова, А. О. Буеверов
Πηγή: Meditsinskiy sovet = Medical Council; № 8 (2023); 150-157 ; Медицинский Совет; № 8 (2023); 150-157 ; 2658-5790 ; 2079-701X
Θεματικοί όροι: вирус гепатита С, CHC, ferritin, hyperferritinemia, elevated ferritin levels, hepatitis C virus, ХГС, ферритин, гиперферритинемия, повышение уровня ферритина
Περιγραφή αρχείου: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/7566/6739; Valenti L., Corradini E., Adams L.A., Aigner E., Alqahtani S., Arrese M. et al. Consensus Statement on the definition and classification of metabolic hyperferritinaemia. Nat Rev Endocrinol. 2023;17:1–12. https://doi.org/10.1038/s41574-023-00807-6.; Adams P.C., Reboussin D.M., Barton J.C., McLaren C.E., Eckfeldt J.H., McLaren G.D. et al. Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005;352(17):1769–1778. https://doi.org/10.1056/NEJMoa041534.; Zhou B., Liu S., Yuan G. Combined Associations of Serum Ferritin and Body Size Phenotypes With Cardiovascular Risk Profiles: A Chinese Population-Based Study. Front Public Health. 2021;9:550011. https://doi.org/10.3389/fpubh.2021.550011.; Масленникова Г.Я., Оганов Р.Г. Профилактика неинфекционных заболеваний как возможность увеличения ожидаемой продолжительности жизни и здорового долголетия. Кардиоваскулярная терапия и профилактика. 2019;18(2):5–12. https://doi.org/10.15829/1728-8800-2019-2-5-12.; Самородская И.В., Ключников И.В. Проблемы диагностики и лечения COVID-19 на клиническом примере. Врач. 2020;(4):19–25. https://doi.org/10.29296/25877305-2020-04-04.; Lazar A.M. Hyperferritinemia: The Link Between COVID-19, Inflammation, and Patient Comorbidities. IDHealth. 2021;4(4):615–622. https://doi.org/10.47108/jidhealth.Vol4.Iss4.193.; Богомолов П.О., Сапанюк А.И., Буеверов А.О., Висков Р.В., Соболев К.Э., Ушканенко И.Н. и др. Организация медицинской помощи пациентам с заболеваниями печени в Московской области. Вестник Росздравнадзора. 2022;(6):19–27. Режим доступа: https://www.roszdravnadzor.gov.ru/i/upload/images/2023/2/5/1675624939.70676-1-1410742.pdf.; Саркисянц Н.К., Григорян Э.Г. Прогностическая значимость уровня ферритинемии у больных хроническим гепатитом С. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2013;23(3):56–59. Режим доступа: http://old-gastro-j.ru/files/_3_2013_s9_1372602993.pdf.; Цветаева Н.В., Левина А.А., Мамукова Ю.И. Основы регуляции обмена железа. Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2010;3(3):278–283. Режим доступа: https://www.elibrary.ru/item.asp?edn=mwezqf.; Sandnes M., Ulvik R.J., Vorland M., Reikvam H. Hyperferritinemia – A Clinical Overview. J Clin Med. 2021;10(9):2008. https://doi.org/10.3390/jcm10092008.; Perricone C., Bartoloni E., Bursi R., Cafaro G., Guidelli G.M., Shoenfeld Y., Gerli R. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunol Res. 2020;68(4):213–224. https://doi.org/10.1007/s12026-020-09145-5.; Каледа М.И., Федоров Е.С. Значение гиперферритинемии как диагностического и прогностического биомаркера. Современная ревматология. 2022;16(2):74–80. https://doi.org/10.14412/1996-7012-2022-2-74-80.; Ruscitti P., Di Benedetto P., Berardicurti O., Panzera N., Grazia N., Lizzi A.R. et al. Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations. Sci Rep. 2020;10:12232. https://doi.org/10.1038/s41598-020-69031-w.; Cheng L., Li H., Li L., Liu C., Yan S., Chen H., Li Y. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal. 2020;34:e23618. https://doi.org/10.1002/jcla.23618.; Moreira A.C., Mesquita G., Gomes M.S. Ferritin: An Inflammatory Player Keeping Iron at the Core of Pathogen-Host Interactions. Microorganisms. 2020;8:589. https://doi.org/10.3390/microorganisms8040589.; Deng F., Zhang L., Lyu L., Lu Z., Gao D., Ma X. et al. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19. Med Clin (Barc). 2021;156(7):324–331. https://doi.org/10.1016/j.medcli.2020.11.030.; Alam J.M., Ali H. Significance of Ferritin as Biomarker in SARS Corona virus (COVID-19) infection and complications: A Review. Chem Res J. 2020;5(6):59–64. Available at: http://chemrj.org/download/vol-5-iss-6-2020/chemrj-2020-05-06-59-64.pdf.; Plays M., Müller S., Rodriguez R. Chemistry and biology of ferritin. Metallomics. 2021;13(5):mfab021. https://doi.org/10.1093/mtomcs/mfab021.; Zhang J., Chen X., Hong J., Tang A., Liu Y., Xie N. et al. Biochemistry of mammalian ferritins in the regulation of cellular iron homeostasis and oxidative responses. Sci China Life Sci. 2021;64(3):352–362. https://doi.org/10.1007/s11427-020-1795-4.; Habib H.M., Ibrahim S., Zaim A., Ibrahim W.H. The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomed Pharmacother. 2021;136:111228. https://doi.org/10.1016/j.biopha.2021.111228.; Birndt S., Schenk T., Heinevetter B., Brunkhorst F.M., Maschmeyer G., Rothmann F. et al. Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide. German registry. J Cancer Res Clin Oncol. 2020;146:1065–1077. https://doi.org/10.1007/s00432-020-03139-4.; Schulert G.S., Canna S.W. Convergent pathways of the hyperferritinemic syndromes. Int Immunol. 2018;30:195–203. https://doi.org/10.1093/intimm/dxy012.; Tran T.N., Eubanks S.K., Schaffer K.J., Zhou C.Y., Linder M.C. Secretion of Ferritin by Rat Hepatoma Cells and Its Regulation by Inflammatory Cytokines and Iron. Blood. 1997;90(12):4979–4986. https://doi.org/10.1182/blood.V90.12.4979.; Torti F.M., Torti S.V. Regulation of ferritin genes and protein. Blood. 2002;99(10):3505–3516. https://doi.org/10.1182/blood.v99.10.3505.; Kernan K.F., Carcillo J.A. Hyperferritinemia and inflammation. Int Immunol. 2017;29(9):401–409. https://doi.org/https://doi.org/10.1093/intimm/dxx031.; Rosário C., Zandman-Goddard G., Meyron-Holtz E.G., D’Cruz D.P., Shoenfeld Y. The hyperferritinemic syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 2013;11:185. https://doi.org/10.1186/1741-7015-11-185.; Para O., Caruso L., Pestelli G., Tangianu F., Carrara D., Maddaluni L. et al. Ferritin as prognostic marker in COVID-19: the FerVid study. Postgrad Med. 2022;134(1):58–63. https://doi.org/10.1080/00325481.2021.1990091.; Gómez-Pastora J., Weigand M., Kim J., Wu X., Strayer J., Palmer A.F. et al. Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator? Clin Chim Acta. 2020;509:249–251. https://doi.org/10.1016/j.cca.2020.06.033.; Kappert K., Jahić A., Tauber R. Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases. Biomarkers. 2020;25(8):616–625. https://doi.org/10.1080/1354750X.2020.1797880.; Cavezzi A., Troiani E., Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin Pract. 2020;10(2):1271. https://doi.org/10.4081/cp.2020.1271.; Čepelak I., Dodig S., Vučenik I. Hyperferritinemia and COVID-19? RAD CASA – Medical Sciences. 2020;544:18–25. https://doi.org/10.21857/ygjwrcdv0y.; Zou D.M., Sun W.L. Relationship between Hepatitis C Virus Infection and Iron Overload. Chin Med J (Engl). 2017;130(7):866–871. https://doi.org/10.4103/0366-6999.202737.; Kakizaki S., Takagi H., Horiguchi N., Toyoda M., Takayama H., Nagamine T. et al. Iron enhances hepatitis C virus replication in cultured human hepatocytes. Liver. 2000;20(2):125–128. https://doi.org/10.1034/j.1600-0676.2000.020002125.x.; Foka P., Dimitriadis A., Karamichali E., Kyratzopoulou E., Giannimaras D., Koskinas J. et al. Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency. Virulence. 2016;7:679-690. https://doi.org/10.1080/21505594.2016.1175700.; Fillebeen C., Pantopoulos K. Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells. J Hepatol. 2010;53:995-999. https://doi.org/10.1016/j.jhep.2010.04.044.; Di Bisceglie A.M., Axiotis C.A., Hoofnagle J.H., Bacon B.R. Measurements of iron status in patients with chronic hepatitis. Gastroenterology. 1992;102(6):2108–2113. https://doi.org/10.1016/0016-5085(92)90339-z.; Hézode C., Cazeneuve C., Coué O., Roudot-Thoraval F., Lonjon I., Bastie A. et al. Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions. J Hepatol. 1999;31(6):979–984. https://doi.org/10.1016/s0168-8278(99)80308-0.; Nishina S., Hino K., Korenaga M., Vecchi C., Pietrangelo A., Mizukami Y. et al. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology. 2008;134(1):226–238. https://doi.org/10.1053/j.gastro.2007.10.011.; Miura K., Taura K., Kodama Y., Schnabl B., Brenner D.A. Hepatitis C virusinduced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology. 2008;48(5):1420–1429. https://doi.org/10.1002/hep.22486.; Taher A.T., Saliba A.N. Iron overload in thalassemia: different organs at different rates. Hematology Am Soc Hematol Educ Program. 2017;2017(1):265–271. https://doi.org/10.1182/asheducation-2017.1.265.; Metwally M.A., Zein C.O., Zein N.N. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol. 2004;99:286-291. https://doi.org/10.1111/j.1572-0241.2004.04049.x.; Щекотова А.П., Булатова И.А. Вклад изменений обмена железа в патогенез хронических диффузных заболеваний печени. Пермский медицинский журнал. 2020;37(6):5–12. https://doi.org/10.17816/pmj3765-12.; Inomata S., Anan A., Yamauchi E., Yamauchi R., Kunimoto H., Takata K. et al. Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents. Intern Med. 2019;58(20):2915–2922. https://doi.org/10.2169/internalmedicine.2909-19.; Tan T.C., Crawford D.H., Franklin M.E., Jaskowski L.A., Macdonald G.A., Jonsson J.R. et al. The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis. Liver Int. 2012;32(9):1391–1399. https://doi.org/10.1111/j.1478-3231.2012.02828.x.; Martinez M.A., Franco S. Impact of COVID-19 in Liver Disease Progression. Hepatol Commun. 2021;5(7):1138–1150. https://doi.org/10.1002/hep4.1745.; Беляков Н.А., Боева Е.В., Загдын З.М., Эсауленко Е.В., Лиознов Д.А., Симакина О.Е. и др. Эпидемиология и течение инфекционных заболеваний на фоне пандемии COVID-19. Сообщение 1. ВИЧ-инфекция, хронический гепатит С и туберкулез. Инфекция и иммунитет. 2022;12(4):639–650. https://doi.org/10.15789/2220-7619-EAC-1958.; Jang T.Y. Suppression of hepatitis C virus replication during COVID-19 infection. Kaohsiung J Med Sci. 2022;38(4):394–395. https://doi.org/10.1002/kjm2.12498.; Toma L., Zgura A., Isac T., Simu R., Mercan-Stanciu A., Dodot M., Iliescu E.L. COVID-19 and the thyroid function in patients with HCV-associated hepatocellular carcinoma. Acta Endocrinol (Buchar). 2022;18(3):392–396. https://doi.org/10.4183/aeb.2022.392.; Mangia A., Cenderello G., Verucchi G., Ciancio A., Fontana A., Piazzolla V. et al. Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis? World J Clin Cases. 2020;8(22):5831–5834. https://doi.org/10.12998/wjcc.v8.i22.5831.; Ronderos D., Omar A.M.S., Abbas H., Makker J., Baiomi A., Sun H. et al. Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality. World J Clin Cases. 2021;9(29):8749–8762. https://doi.org/10.12998/wjcc.v9.i29.8749.
-
2Academic Journal
Συγγραφείς: Yu. S. Polushin, I. V. Shlyk, E. G. Gavrilova, E. V. Parshin, A. M. Ginzburg, Ю. С Полушин, И. В. Шлык, Е. Г. Гаврилова, Е. В. Паршин, А. М. Гинзбург
Πηγή: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 18, № 4 (2021); 20-28 ; Вестник анестезиологии и реаниматологии; Том 18, № 4 (2021); 20-28 ; 2541-8653 ; 2078-5658
Θεματικοί όροι: цитокиновый шторм, ferritin, hyperferritinemia, cytokine storm, ферритин, гиперферритинемия
Περιγραφή αρχείου: application/pdf
Relation: https://www.vair-journal.com/jour/article/view/549/500; Гудима Г. О., Хаитов Р. М., Кудлай Д. А., Хаитов М. Р Молекулярно-иммунологические аспекты диагностики, профилактики и лечения коронавирусной инфекции // Иммунология. - 2021. - Т. 42, № 3. - Р. 198210. DOI: https://doi.org/10.33029/0206-4952-2021-42-3-198-210.; Кузнецов И. А., Потиевская В. И., Качанов И. В. и др. Роль ферритина в биологических средах человека // Современные проблемы науки и образования (электронный журнал). - 2017. - № 5. https://science-education. ru/ru/article/view?id=27102.; Лодягин А. Н., Батоцыренов Б. В., Шикалова И. А. и др. Ацидоз и токсический гемолиз - цели патогенетического лечения полиорганной патологии при COVID-19 // Вестник восстановительной медицины. - 2020. - Т. 97, № 3. - С. 25-30. https://doi.org/10.38025/ 2078-1962-2020-97-3-25-3.; Мамаев А. Н., Кудлай Д. А. Статистические методы в медицине. - М.: Практическая медицина, 2021. - 136 с.; Орлов Ю. П., Долгих В. Т., Верещагин Е. И. и др. Есть ли связь обмена железа с течением COVID-19? // Вестник анестезиологии и реаниматологии. - 2020. - Т. 17, № 4. - С. 6-13. https://doi.org/10.21292/2078-5658-2020-17-4-6-13.; Орлов Ю. П., Иванов А. В., Долгих В. Т. Нарушения обмена железа в патогенезе критических состояний // Общая реаниматология. - 2011. - Т. VII, № 5. - С. 15-19. https://doi.org/10.15360/1813-9779-2011-5-15.; Cheng L., Li H., Li L. et al. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis // J. Clin. Lab. Anal. - 2020. - № 34. - Р. e23618. https://doi.org/10.1002/jcla.23618.; Colafrancesco S., Alessandri C., Conti F. et al. COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? // Autoimmun Rev. - 2020. - № 19. - Р. 102573. doi:10.1016/j.autrev.2020.102573.; Diao Bo, Wang Ch., Wang R. et al. Human kidney is a target for novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) // Infection. medRxiv. - 2020. - DOI:10.1101/2020.03.04.20031120.; Feld J., Tremblay D., Thibaud S. et al. Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis // Int. J. Lab. Hematol. - 2020. - № 42. - Р. 773-779. https://doi.org/10.1111/ijlh.13309.; Habib H. M., Ibrahim H. S., Wissam A. Z. et al. The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators // Biomedicine & Pharmacotherapy. - 2021. - Vol. 136. - Р. 111228. https://doi.org/10.1016/j.biopha.2021.111228; Kappert K., Jahic A., Tauber R. Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases // Biomarkers. - 2020. - DOI:10.1080/1354750X.2020.1797880.; Malkova A., Kudlay D., Kudryavtsev I., Starshinova A., Yablonskiy P., Shoenfeld, Y. Immunogenetic Predictors of Severe COVID-19 // Vaccines. - 2021. - № 9. - Р. 211. doi.org/10.3390/vaccines9030211.; Pastoraa J. G., Weiganda M., Kim J. et al. Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator? // Clin. Chim. Acta. - 2020. - № 509. - P. 249-251 https://doi.org/10.1016/j.cca.2020.06.033.; Perricone C., Bartoloni E., Bursi R. et al. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy // Immunol. Res. - 2020. - № 68. - Р 213-224. https://doi.org/10.1007/s12026-020-09145-5.; Rosario C., Z andm an-G oddard G., M eyron-H oltz E. G. et al. The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome // BMC Med. - 2013. - № 11. - Р 185. doi:10.1186/1741-7015-11-185.; Ruan Q., Yang K., Wang W. et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China // Intens. Care Med. - 2020. - № 46. - Р. 846-848. doi:10.1007/s00134-020-05991-x.
-
3Academic Journal
Συγγραφείς: Антофійчук, T.M., Хухліна, О.С., Антофійчук, М.П.
Πηγή: Clinical and experimental pathology; Vol. 20 No. 1 (2021) ; Клиническая и экспериментальная патология; Том 20 № 1 (2021) ; Клінічна та експериментальна патологія; Том 20 № 1 (2021) ; 2521-1153 ; 1727-4338
Θεματικοί όροι: nonalcoholic steatohepatitis, plasmapharesis, hyperferritinemia, serum iron, obesity, неалкогольный стеатогепатит, плазмаферез, гиперферритинемия, сывороточное железо, ожирение, неалкогольний стеатогепатит, гіперферитинемія, сироваткове залізо, ожиріння
Περιγραφή αρχείου: application/pdf
Relation: http://cep.bsmu.edu.ua/article/view/232600/231366; http://cep.bsmu.edu.ua/article/view/232600
-
4Academic Journal
Συγγραφείς: J. H. Khizroeva, A. D. Makatsariya, V. O. Bitsadze, M. V. Tretyakova, E. V. Slukhanchuk, I. Elalamy, J.-C. Gris, L. S. Radetskaya, N. A. Makatsariya, Ya. Yu. Sulina, V. I. Tsibizova, A. S. Shkoda, D. V. Blinov, Д. Х. Хизроева, А. Д. Макацария, В. О. Бицадзе, М. В. Третьякова, Е. В. Слуханчук, И. Элалами, Ж.-К Гри, Л. С. Радецкая, Н. А. Макацария, Я. Ю. Сулина, В. И. Цибизова, А. С. Шкода, Д. В. Блинов
Πηγή: Obstetrics, Gynecology and Reproduction; Vol 14, No 2 (2020); 132-147 ; Акушерство, Гинекология и Репродукция; Vol 14, No 2 (2020); 132-147 ; 2500-3194 ; 2313-7347
Θεματικοί όροι: лейкопения, laboratory monitoring of COVID-19 patients, coagulopathy, DIC, D-dimer, fibrinogen, hyperferritinemia, lymphopenia, thrombocytopenia, leukopenia, лабораторный мониторинг пациентов с COVID-19, коагулопатия, ДВС-синдром, Д-димер, фибриноген, гиперферритинемия, лимфопения, тромбоцитопения
Περιγραφή αρχείου: application/pdf
Relation: https://www.gynecology.su/jour/article/view/642/800; https://www.gynecology.su/jour/article/view/642/801; Rajgor D.D., Lee M.H., Archuleta S. et al. The many estimates of the COVID-19 case fatality rate. Lancet Infect Dis. 2020 Mar 27. pii: S1473- 3099(20)30244-9. DOI:10.1016/S1473-3099(20)30244-9.; Тамм М.В. Коронавирусная инфекция в Москве: прогнозы и сценарии. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2020;13(1):43–51. DOI:10.17749/2070-4909.2020.13.1.43-51.; Гончарова Е.В., Донников А. Е., Кадочникова В.В. и др. Диагностика вируса, вызывающего COVID-19, методом ПЦР в реальном времени. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2020;13(1):52–63. DOI:10.17749/2070-4909.2020.13.1.52-63.; Adhikari S.P., Meng S., Wu Y. J. et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9(1):29. DOI:10.1186/s40249-020-00646-x.; Dhama K., Sharun K., Tiwari R. et al. Coronavirus Disease 2019 – COVID-19. 2020;2019. [Electronic resource]. Available at: https://www.preprints.org/manuscript/202003.0001. [Accessed: 28.04.2020].; Макацария А.Д., Григорьева К.Н., Мингалимов М.А. и др. Коронавирусная инфекция (COVID-19) и синдром диссеминированного внутрисосудистого свертывания. Акушерство, гинекология и репродукция. 2020;14(2):[принятая рукопись]. DOI:10.17749/2313-7347.132.; Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Версия 6 (28.04.2020). Министерство здравоохранения Российской Федерации, 2020. 165 с. Режим доступа: https://remedium.ru/legislation/other/Vremennye_metodicheskie_rekomendatsii_profilaktika_diagnostika_i_lechenie_novoy_covid_19_v6. [Дата доступа: 28.04.2020].; Weitz J.S., Beckett S. J., Coenen A.R. et al. Intervention serology and interaction substitution: modeling the role of ‘shield immunity’ in reducing COVID-19 epidemic spread. MedRxiv. 2020. DOI:10.1101/2020.04.01.20049767.; Coronavirus disease (COVID-19) technical guidance: Surveillance and case definitions. [Electronic resource]. WHO, 2020. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technicalguidance/surveillance-and-case-definitions. [Accessed: 28.04.2020].; Lippi G., Salvagno GL, Pegoraro M. et al. Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays. Clin Chem Lab Med. 2020 Apr 16. pii: /j/cclm.ahead-of-print/cclm-2020-0473/cclm-2020- 0473.xml. DOI:10.1515/cclm-2020-0473. [Epub ahead of print].; Hu X., An T., Situ B. et al. Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS-CoV-2. MedRxiv. 2020. DOI:10.1101/2020.03.12.20034231.; Liu L., LiuW., Wang S., Zheng S. A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) in 238 admitted hospital patients. MedRxiv. 2020. DOI:10.1101/2020.03.06.20031856.; Lassaunière R., Frische A., Harboe Z.B. et al. Evaluation of nine commercial SARS-CoV-2 immunoassays. MedRxiv. 2020. DOI:10.1101/2020.04.09.20056325.; Infantino M., Damiani A., Gobbi FL. et al. Serological assays for SARSCoV-2 infectious disease: benefits, limitations and perspectives. Isr Med Assoc J. 2020;22:203–10.; Макацария А.Д., Бицадзе В.О., Хизроева Д.Х. и др. Новая коронавирусная инфекция (COVID-19) и группы риска в акушерстве и гинекологии. Акушерство, гинекология и репродукция. 2020;14(2):[принятая рукопись]. DOI:10.17749/2313-7347.133.; Sun Y., DongY., Wang L. et al. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. J Autoim. 2020 Apr 24: 102473. DOI:10.1016/j.jaut.2020.102473. [Epub ahead of print].; Carboni E., Carta A. R., Carboni E. Can pioglitazone be potentially useful therapeutically in treating patients with covid-19? Med Hypotheses. 2020 Apr 22: 109776. DOI:10.1016/j.mehy.2020.109776. [Epub ahead of print].; Wang F., Hou H., Luo Y. et al. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020. DOI:10.1172/jci.insight.137799.; Velavan T.P., Meyer C.G. Mild versus severe COVID-19: laboratory markers. Int J Infect Dis. 2020;95:304–7. DOI:10.1016/j.ijid.2020.04.061. [Epub ahead of print].; Zhao W., He L., Xie X., Liu J. The viral load of 2019 novel Coronavirus (COVID-19) has the potential to predict the clinical outcomes. Lancet. 2000 Feb 24. 22 p. Available at: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3546047. [Accessed: 28.04.2020].; Sun S., Cai X., Wang H. et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta. 2020;507:174– 80. DOI:10.1016/j.cca.2020.04.024. [Epub ahead of print].; Terpos E., Ntanasis-Stathopoulos I., Elalamy I. et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020 Apr 13. DOI:10.1002/ajh.25829.; Мингалимов М.А., Григорьева К.Н., Третьякова М.В. и др. Синдром диссеминированного внутрисосудистого свертывания в перинатальной медицине. Акушерство, гинекология и репродукция. 2020;14(1):56–68. DOI:10.17749/2313-7347.2020.14.1.56-68.; Josefs T., Barrett T. J., Brown E. J. et al. Neutrophil Extracellular Traps (NETs) promote macrophage inflammation and impair atherosclerosis resolution in diabetic mice. JCI Insight. 2020;5(7). pii: 134796. DOI:10.1172/jci.insight.134796.; Adam S.S., Key N.S., Greenberg C.S. D-dimer antigen: current concepts and future prospects. Blood. 2009;113(13):2878–87. DOI:10.1182/blood-2008-06-165845.; Eichinger S., Minar E., Bialonczyk C. et al. D-dimer levels and risk of recurrent venous thromboembolism. JAMA. 2003;290(8):1071–4. DOI:10.1001/jama.290.8.1071.; Verhovsek M., Douketis J.D., Yi Q. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med. 2008;149(7):481–90, W94. DOI:10.7326/0003-4819-149-7-200810070-00008.; Hack C. E. Fibrinolysis in disseminated intravascular coagulation. Semin Thromb Hemost. 2001;27(6):633–8. DOI:10.1055/s-2001-18867.; Wada T., Gando S., Mizugaki A. et al. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome–fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction. Thromb Res. 2013;132(1):e64–9. DOI:10.1016/j.thromres.2013.05.010.; Llitjos J. F., Leclerc M., Chochois C. et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020 Apr 22. DOI:10.1111/jth.14869. [Epub ahead of print].; Thachil J., Tang N., Gando S. et al. Laboratory haemostasis monitoring in COVID-19. J Thromb Haemost. 2020 Apr 23. DOI:10.1111/jth.14866. [Epub ahead of print].; Klok F.A., Kruipb M. J.H.A, van der Meerc N. J.M. et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020 Apr 10. DOI:10.1016/j.thromres.2020.04.013. [Epub ahead of print].; Ranucci M., Ballotta A., Di Dedda U. et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020 Apr 17. DOI:10.1111/jth.14854. [Epub ahead of print].; Diagnosis and Treatment Protocol for COVID-19 (Trial Version 7). 2020. Available at: http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.sht. [Accessed: 28.04.2020].; Yang M., Ng M.H., Li C.K. Thrombocytopenia in patients with severe acute respiratory syndrome (review). Hematology. 2005;10(2):101–5. DOI:10.1080/10245330400026170.; Zhai Z., Li C., Chen Y. et al. Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines. Thromb Haemost. 2020 Apr 21. DOI:10.1055/s-0040-1710019. [Epub ahead of print].; Bikdeli B., Madhavan М.V., Jimenez D. et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020 Apr 15. pii: S0735- 1097(20)35008-7. DOI:10.1016/j.jacc.2020.04.031. [Epub ahead of print].; Wang W., Knovich M.A., Coffman L.G. et al. Serum ferritin: past, present and future. Biochim Biophys Acta. 2010;1800(8):760–9. DOI:10.1016/j.bbagen.2010.03.011; Knovich M.A., Storey J.A., Coffman L.G. et al. Ferritin for the clinician. Blood Rev. 2009;23(3):95–104. DOI:10.1016/j.blre.2008.08.001.; Blankenhaus B., Braza F., Martins R. et al. Ferritin regulates organismal energy balance and thermogenesis. Mol Metab. 2019;24:64–79. DOI:10.1016/j.molmet.2019.03.008.; Moore C., Ormseth M., Fuchs H. Causes and significance of markedly elevated serum ferritin levels in an academic medical center. J Clin Rheumatol. 2013;19(6):324–8. DOI:10.1097/RHU.0b013e31829ce01f.; Sungkar T., Rozi M. F., Dairi L.B., Zain L.H. Serum ferritin levels: a potential biomarker to represent Child-Turcotte-Pugh score among decompensated liver cirrhosis patients. Malays J Med Sci. 2019;26(2):59–65. DOI:10.21315/mjms2019.26.2.7.; Umer N., Makki M.U., Kiran S.K., Jadoon N.A. Serum ferritin as a predictor of 30 days mortality in patients of decompensated chronic liver disease. J Ayub Med Coll Abbottabad. 2017;29(3):415–8.; Tan L., Wang Q., Zhang D. et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5(1):1–3. DOI:10.1038/s41392-020-0148-4.; Lui J., Li H., Luo M. et al. Lymphopenia acted as an adverse factor for severity in patients with COVID-19: a single-centered, retrospective study. Infect Dis. 2020. DOI:10.21203/rs.3.rs-22849/v1.; Henry B.M. COVID-19, ECMO, and lymphopenia: a word of caution. Lancet Respir Med. 2020;8(4):e24. DOI:10.1016/S2213-2600(20)30119-3.; Li J., Li M., Zheng S. et al. Leukopenia predicts risk for death in critically ill patients with COVID-19 in Wuhan, China: a single-centered, retrospective study. Lancet Infect Dis. 2020. 26 p. Available at: https://ssrn.com/abstract=3555248. [Accessed: 28.04.2020].; Yang W., Cao Q., Qin L. et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020;80(4):388–93. DOI:10.1016/j.jinf.2020.02.016.; Li Y.X, Wu W., Yang T. et al. Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19. Zhonghua Nei Ke Za Zhi. 2020;59(0):E003. (In Chinese). DOI: 3760.10/cma.j.cn112138-20200221-00114. [Epub ahead of print].; Lippi G., Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Clin Chim Acta. 2020;505:190–1. DOI:10.1016/j.cca.2020.03.004.; Zhang Y., Xiao M., Zhang S. et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38. DOI:10.1056/NEJMc2007575.; Baig A. M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995–8. DOI:10.1021/acschemneuro.0c00122.; Wu Y., Xu X., Chen Z. et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020 Mar 30. pii: S0889-1591(20)30357-3. DOI:10.1016/j.bbi.2020.03.031. [Epub ahead of print].; Steardo L., Steardo L., Zorec R., Verkhratsky A. Neuroinfection may potentially contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf). 2020 Mar 29:e13473. DOI:10.1111/apha.13473. [Epub ahead of print].; https://www.gynecology.su/jour/article/view/642
-
5Academic Journal
Συγγραφείς: Makatsariya A.D., Slukhanchuk E.V., Bitsadze V.O., Khizroeva J.K., Tretyakova M.V., Tsibizova V.I., Shkoda A.S., Grandone E., Elalamy I., Rizzo G., Gris J.R., Schulman S., Brenner B.
Συνεισφορές: 1
Πηγή: Annals of the Russian academy of medical sciences; Vol 75, No 4 (2020); 306-317 ; Вестник Российской академии медицинских наук; Vol 75, No 4 (2020); 306-317 ; 2414-3545 ; 0869-6047 ; 10.15690/vramn.754
Θεματικοί όροι: COVID-19, SARS-COV-2, coagulopathy, DIC-syndrome, D-dimer, fibrinogen, hyperferritinemia, hypercytokinemia, cytokine storm, antiphospholipid antibodies, low molecular weight heparin, коагулопатия, ДВС-синдром, Д-димер, фибриноген, гиперферритинемия, гиперцитокинемия, цитокиновый «шторм», антифосфолипидные антитела, низкомолекулярные гепарины
Περιγραφή αρχείου: application/pdf
Relation: https://vestnikramn.spr-journal.ru/jour/article/view/1368/1285; https://vestnikramn.spr-journal.ru/jour/article/view/1368/1295; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/1368/1509; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/1368/1510; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/1368/1511; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/1368/1512; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/1368/1513; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/1368/1514
-
6Academic Journal
Συγγραφείς: Bitsadze V.O., Khizroeva J.K., Makatsariya A.D., Slukhanchuk E.V., Tretyakova M.V., Rizzo G., Gris J., Elalamy I., Serov V.N., Shkoda A.S., Samburova N.V.
Συνεισφορές: 1
Πηγή: Annals of the Russian academy of medical sciences; Vol 75, No 3 (2020); 214-225 ; Вестник Российской академии медицинских наук; Vol 75, No 3 (2020); 214-225 ; 2414-3545 ; 0869-6047 ; 10.15690/vramn.753
Θεματικοί όροι: COVID-19, рemophagocytic lymphohistiocytosis, hyperferritinemia, DIC-syndrome, immunothrombosis, hyper-inflammation, low-molecular-weight heparin, pentoxifylline, anticytokine therapy, sepsis and pregnancy, гемофагоцитарный лимфогистиоцитоз, гиперферритинемия, коагулопатия, ДВС-синдром, иммунотромбоз, гипервоспаление, низкомолекулярные гепарины, пентоксифиллин, антицитокиновая терапия, сепсис и беременность
Περιγραφή αρχείου: application/pdf
Relation: https://vestnikramn.spr-journal.ru/jour/article/view/1336/1222; https://vestnikramn.spr-journal.ru/jour/article/view/1336/1261; https://vestnikramn.spr-journal.ru/jour/article/view/1336/1268; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/1336/1434; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/1336/1435; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/1336/1436; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/1336/1445
-
7Academic Journal
Συγγραφείς: Полякова, Светлана, Анушенко, Антон, Баканов, Михаил, Смирнов, Иван
Θεματικοί όροι: ОБМЕН ЖЕЛЕЗА, ПЕРЕГРУЗКА ЖЕЛЕЗОМ, ГИПЕРФЕРРИТИНЕМИЯ, ХРОНИЧЕСКИЕ БОЛЕЗНИ ПЕЧЕНИ, ДЕТИ
Περιγραφή αρχείου: text/html
-
8Academic Journal
Πηγή: Российский педиатрический журнал.
Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, ОБМЕН ЖЕЛЕЗА, ПЕРЕГРУЗКА ЖЕЛЕЗОМ, ГИПЕРФЕРРИТИНЕМИЯ, ХРОНИЧЕСКИЕ БОЛЕЗНИ ПЕЧЕНИ, ДЕТИ, 3. Good health
Περιγραφή αρχείου: text/html
